Membrane Oxygenators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031

Description

The latest market analysis by Fairfield Market Research unveils significant growth prospects for the global Membrane Oxygenators Market. The market, valued at USD 139.23 million in 2024, is projected to reach USD 162.7 million by 2031, growing at a CAGR of 2.30%. With a steady compound annual growth rate (CAGR), the market is projected to experience substantial valuation increases over the coming decade. The report underscores the pivotal role of hollow fiber membrane oxygenators, regional market dynamics, and the transformative impact of technological innovations.

Market Overview

The Membrane Oxygenators Market has demonstrated consistent growth, driven by the escalating prevalence of cardiopulmonary disorders. This surge is attributed to factors such as poor dietary habits, sedentary lifestyles, and increased smoking rates, which collectively contribute to the rise in respiratory and cardiovascular illnesses. As membrane oxygenators become increasingly integral in treating pediatric, adult, and elderly patients, the market is set to achieve significant dollar growth in the forecast period.

Key Drivers Propelling Demand

Several factors are catalyzing the demand for membrane oxygenators:

Rising Prevalence of Cardiopulmonary Disorders: The increasing incidence of respiratory and cardiovascular conditions necessitates advanced oxygenation solutions.
Expansion of Extracorporeal Membrane Oxygenation (ECMO) Centers: The growing number of ECMO facilities enhances the adoption of membrane oxygenators as critical support devices.
Advancements in Membrane Technology: Improvements in mass transfer efficiency and membrane durability are facilitating the replacement of traditional bubble oxygenators, thereby expanding the application scope of membrane oxygenators.
Enhanced Device Availability: The introduction of infant and adult-specific oxygenators caters to a broader patient demographic, further driving market growth.

Market Restraints

Despite robust growth, the market faces certain challenges:

Strict Regulatory Standards: Compliance with stringent regulatory frameworks, particularly for Class II medical devices, poses significant hurdles for market players.
Risks Associated with Oxygenation Systems: Potential complications linked to oxygenation procedures can impede market expansion.
Adoption of Minimally Invasive Procedures: The rise of less invasive treatment alternatives may limit the widespread use of membrane oxygenators in certain clinical settings.

Regional Insights

North America: Leading the Market

North America remains the dominant region, accounting for the largest market share. This leadership is supported by a well-established healthcare infrastructure, comprehensive reimbursement systems, and substantial government funding. Additionally, heightened awareness and technological advancements in membrane oxygenators contribute to the region's sustained growth.

Asia Pacific: Emerging Opportunities

The Asia Pacific region presents significant growth opportunities, driven by the increasing prevalence of chronic diseases such as heart disease and the rising awareness of membrane oxygenator benefits. Government initiatives and investments by multinational corporations in emerging economies like China are expected to bolster market expansion. The region's large population base and demand for cost-effective treatment solutions further enhance its market potential.

Category Insights

Product Type: Hollow Fiber Membrane Oxygenators Leading the Charge

Hollow fiber membrane oxygenators dominate the market, supported by their superior gas exchange capabilities and rapid de-airing features. These devices are increasingly integrated into ECMO circuits, especially for emergency support following cardiac events. Conversely, flat sheet membrane oxygenators, known for their extended life cycles, are gaining traction due to their suitability for long-term use, despite requiring specialized gas cleansing processes.

Age Group: Adults and Neonates

The adult segment holds a significant market share, driven by the high incidence of cardiogenic shock and advancements in membrane oxygenator technology tailored for adult patients. Innovations such as pump-less veno-arterial extracorporeal gas support systems and double-lumen cannulas are enhancing treatment efficacy.

In the neonate segment, membrane oxygenators are essential for treating infants with respiratory and cardiac failures. However, the emergence of minimally invasive therapies is gradually reducing the reliance on these devices for newborns, despite the ongoing need driven by a substantial number of ECMO treatments globally.

Application: Respiratory Dominates

The respiratory application category leads the market, with membrane oxygenators playing a critical role in managing severe respiratory conditions like respiratory failure, acute respiratory distress syndrome (ARDS), and pneumonia. These devices function as artificial lungs, maintaining pulmonary function and addressing the rising global prevalence of respiratory disorders, including asthma.

Impact of Covid-19

The Covid-19 pandemic significantly influenced the membrane oxygenators market, with heightened demand for oxygenation devices in acute Covid-19 cases. Manufacturers ramped up production to support the increased need for ECMO treatments in intensive care units. The pandemic underscored the essential role of membrane oxygenators in critical care and surgical procedures, prompting market players to innovate and release enhanced oxygenation solutions.

Competitive Analysis

The membrane oxygenators market is characterized by moderate competition, with key players striving to gain an edge through product innovation and strategic partnerships. Major competitors include MicroPort Scientific Corporation, Nipro Medical Corporation, Medtronic, Fresenius SE & Co KGaA, Terumo Medical Corporation, and Getinge AB.

Recent Developments

Regulatory Approvals: MicroPort Kewei, a subsidiary of MicroPort Scientific Corporation, received expedited approval for its Spiral Diversion Integrated Membrane Oxygenator, facilitating faster market entry for innovative medical devices.
Product Launches: Fresenius Medical Care North America achieved a milestone with the FDA approval of Novalung, the first ECMO system authorized for prolonged use beyond six hours, marking a significant advancement in respiratory and cardiopulmonary support.

Key Companies Profiled

MicroPort Scientific Corporation
Nipro Medical Corporation
Medtronic
Fresenius SE & Co KGaA
Terumo Medical Corporation
Getinge AB

Market Segmentation

By Type:

Hollow Fiber Membrane Oxygenators
Flat Sheet Membrane Oxygenators

By Age Group:

Neonates
Pediatrics
Adults

By Application:

Respiratory (e.g., respiratory failure, ARDS, pneumonia, Covid-19)
Cardiac (e.g., acute myocardial infarction, myocarditis, cardiogenic shock)
ECPR

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)

1. Executive Summary

1.1. Global Membrane Oxygenators Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Membrane Oxygenators Market Outlook, 2019 - 2031

3.1. Global Membrane Oxygenators Market Outlook, by Type, Value (US$ Mn ), 2019 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Hollow Fiber Membrane Oxygenators
  - 3.1.1.2. Flat Sheet Membrane Oxygenators
3.2. Global Membrane Oxygenators Market Outlook, By Application, Value (US$ Mn ), 2019 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Respiratory
    - 3.2.1.1.1. Respiratory failure
    - 3.2.1.1.2. Pulmonary embolism
    - 3.2.1.1.3. Acute respiratory distress syndrome
    - 3.2.1.1.4. Pneumonia
    - 3.2.1.1.5. COVID-19
  - 3.2.1.2. Cardiac
    - 3.2.1.2.1. Acute myocardial infarction
    - 3.2.1.2.2. Myocarditis
    - 3.2.1.2.3. Post-transplant complications
    - 3.2.1.2.4. Decompensated cardiomyopathy
    - 3.2.1.2.5. Cardiogenic shock
  - 3.2.1.3. ECPR
3.3. Global Membrane Oxygenators Market Outlook, by Age Group, Value (US$ Mn ), 2019 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Neonates
  - 3.3.1.2. Paediatrics
  - 3.3.1.3. Adults
3.4. Global Membrane Oxygenators Market Outlook, by Region, Value (US$ Mn ), 2019 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Membrane Oxygenators Market Outlook, 2019 - 2031

4.1. North America Membrane Oxygenators Market Outlook, by Type, Value (US$ Mn ), 2019 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Hollow Fiber Membrane Oxygenators
  - 4.1.1.2. Flat Sheet Membrane Oxygenators
4.2. North America Membrane Oxygenators Market Outlook, By Application, Value (US$ Mn ), 2019 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Respiratory
    - 4.2.1.1.1. Respiratory failure
    - 4.2.1.1.2. Pulmonary embolism
    - 4.2.1.1.3. Acute respiratory distress syndrome
    - 4.2.1.1.4. Pneumonia
    - 4.2.1.1.5. COVID-19
  - 4.2.1.2. Cardiac
    - 4.2.1.2.1. Acute myocardial infarction
    - 4.2.1.2.2. Myocarditis
    - 4.2.1.2.3. Post-transplant complications
    - 4.2.1.2.4. Decompensated cardiomyopathy
    - 4.2.1.2.5. Cardiogenic shock
  - 4.2.1.3. ECPR
4.3. North America Membrane Oxygenators Market Outlook, by Age Group, Value (US$ Mn ), 2019 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Neonates
  - 4.3.1.2. Paediatrics
  - 4.3.1.3. Adults
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Membrane Oxygenators Market Outlook, by Country, Value (US$ Mn ), 2019 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 4.4.1.2. U.S. Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 4.4.1.3. U.S. Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 4.4.1.4. Canada Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 4.4.1.5. Canada Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 4.4.1.6. Canada Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Membrane Oxygenators Market Outlook, 2019 - 2031

5.1. Europe Membrane Oxygenators Market Outlook, by Type, Value (US$ Mn ), 2019 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Hollow Fiber Membrane Oxygenators
  - 5.1.1.2. Flat Sheet Membrane Oxygenators
5.2. Europe Membrane Oxygenators Market Outlook, By Application, Value (US$ Mn ), 2019 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Respiratory
    - 5.2.1.1.1. Respiratory failure
    - 5.2.1.1.2. Pulmonary embolism
    - 5.2.1.1.3. Acute respiratory distress syndrome
    - 5.2.1.1.4. Pneumonia
    - 5.2.1.1.5. COVID-19
  - 5.2.1.2. Cardiac
    - 5.2.1.2.1. Acute myocardial infarction
    - 5.2.1.2.2. Myocarditis
    - 5.2.1.2.3. Post-transplant complications
    - 5.2.1.2.4. Decompensated cardiomyopathy
    - 5.2.1.2.5. Cardiogenic shock
  - 5.2.1.3. ECPR
5.3. Europe Membrane Oxygenators Market Outlook, by Age Group, Value (US$ Mn ), 2019 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Neonates
  - 5.3.1.2. Paediatrics
  - 5.3.1.3. Adults
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Membrane Oxygenators Market Outlook, by Country, Value (US$ Mn ), 2019 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.2. Germany Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.3. Germany Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.4. U.K. Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.5. U.K. Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.6. U.K. Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.7. France Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.8. France Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.9. France Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.10. Italy Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.11. Italy Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.12. Italy Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.13. Turkey Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.14. Turkey Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.15. Turkey Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.16. Russia Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.17. Russia Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.18. Russia Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.19. Rest of Europe Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.20. Rest of Europe Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 5.4.1.21. Rest of Europe Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Membrane Oxygenators Market Outlook, 2019 - 2031

6.1. Asia Pacific Membrane Oxygenators Market Outlook, by Type, Value (US$ Mn ), 2019 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Hollow Fiber Membrane Oxygenators
  - 6.1.1.2. Flat Sheet Membrane Oxygenators
6.2. Asia Pacific Membrane Oxygenators Market Outlook, By Application, Value (US$ Mn ), 2019 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Respiratory
    - 6.2.1.1.1. Respiratory failure
    - 6.2.1.1.2. Pulmonary embolism
    - 6.2.1.1.3. Acute respiratory distress syndrome
    - 6.2.1.1.4. Pneumonia
    - 6.2.1.1.5. COVID-19
  - 6.2.1.2. Cardiac
    - 6.2.1.2.1. Acute myocardial infarction
    - 6.2.1.2.2. Myocarditis
    - 6.2.1.2.3. Post-transplant complications
    - 6.2.1.2.4. Decompensated cardiomyopathy
    - 6.2.1.2.5. Cardiogenic shock
  - 6.2.1.3. ECPR
6.3. Asia Pacific Membrane Oxygenators Market Outlook, by Age Group, Value (US$ Mn ), 2019 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Neonates
  - 6.3.1.2. Paediatrics
  - 6.3.1.3. Adults
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Membrane Oxygenators Market Outlook, by Country, Value (US$ Mn ), 2019 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.2. China Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.3. China Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.4. Japan Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.5. Japan Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.6. Japan Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.7. South Korea Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.8. South Korea Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.9. South Korea Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.10. India Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.11. India Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.12. India Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.13. Southeast Asia Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.14. Southeast Asia Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.15. Southeast Asia Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.16. Rest of Asia Pacific Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.17. Rest of Asia Pacific Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 6.4.1.18. Rest of Asia Pacific Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Membrane Oxygenators Market Outlook, 2019 - 2031

7.1. Latin America Membrane Oxygenators Market Outlook, by Type, Value (US$ Mn ), 2019 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Hollow Fiber Membrane Oxygenators
  - 7.1.1.2. Flat Sheet Membrane Oxygenators
7.2. Latin America Membrane Oxygenators Market Outlook, By Application, Value (US$ Mn ), 2019 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Respiratory
    - 7.2.1.1.1. Respiratory failure
    - 7.2.1.1.2. Pulmonary embolism
    - 7.2.1.1.3. Acute respiratory distress syndrome
    - 7.2.1.1.4. Pneumonia
    - 7.2.1.1.5. COVID-19
  - 7.2.1.2. Cardiac
    - 7.2.1.2.1. Acute myocardial infarction
    - 7.2.1.2.2. Myocarditis
    - 7.2.1.2.3. Post-transplant complications
    - 7.2.1.2.4. Decompensated cardiomyopathy
    - 7.2.1.2.5. Cardiogenic shock
  - 7.2.1.3. ECPR
7.3. Latin America Membrane Oxygenators Market Outlook, by Age Group, Value (US$ Mn ), 2019 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Neonates
  - 7.3.1.2. Paediatrics
  - 7.3.1.3. Adults
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Membrane Oxygenators Market Outlook, by Country, Value (US$ Mn ), 2019 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 7.4.1.2. Brazil Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 7.4.1.3. Brazil Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 7.4.1.4. Mexico Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 7.4.1.5. Mexico Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 7.4.1.6. Mexico Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 7.4.1.7. Argentina Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 7.4.1.8. Argentina Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 7.4.1.9. Argentina Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 7.4.1.10. Rest of Latin America Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 7.4.1.11. Rest of Latin America Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 7.4.1.12. Rest of Latin America Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Membrane Oxygenators Market Outlook, 2019 - 2031

8.1. Middle East & Africa Membrane Oxygenators Market Outlook, by Type, Value (US$ Mn ), 2019 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Hollow Fiber Membrane Oxygenators
  - 8.1.1.2. Flat Sheet Membrane Oxygenators
8.2. Middle East & Africa Membrane Oxygenators Market Outlook, By Application, Value (US$ Mn ), 2019 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Respiratory
    - 8.2.1.1.1. Respiratory failure
    - 8.2.1.1.2. Pulmonary embolism
    - 8.2.1.1.3. Acute respiratory distress syndrome
    - 8.2.1.1.4. Pneumonia
    - 8.2.1.1.5. COVID-19
  - 8.2.1.2. Cardiac
    - 8.2.1.2.1. Acute myocardial infarction
    - 8.2.1.2.2. Myocarditis
    - 8.2.1.2.3. Post-transplant complications
    - 8.2.1.2.4. Decompensated cardiomyopathy
    - 8.2.1.2.5. Cardiogenic shock
  - 8.2.1.3. ECPR
8.3. Middle East & Africa Membrane Oxygenators Market Outlook, by Age Group, Value (US$ Mn ), 2019 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Neonates
  - 8.3.1.2. Paediatrics
  - 8.3.1.3. Adults
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Membrane Oxygenators Market Outlook, by Country, Value (US$ Mn ), 2019 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.2. GCC Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.3. GCC Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.4. South Africa Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.5. South Africa Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.6. South Africa Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.7. Egypt Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.8. Egypt Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.9. Egypt Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.10. Nigeria Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.11. Nigeria Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.12. Nigeria Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.13. Rest of Middle East & Africa Membrane Oxygenators Market by Type, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.14. Rest of Middle East & Africa Membrane Oxygenators Market By Application, Value (US$ Mn ), 2019 - 2031
  - 8.4.1.15. Rest of Middle East & Africa Membrane Oxygenators Market by Age Group, Value (US$ Mn ), 2019 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Market Share Analysis, 2024
9.2. Competitive Dashboard
9.3. Company Profiles
- 9.3.1. MicroPort Scientific Corporation
  - 9.3.1.1. Company Overview
  - 9.3.1.2. Product Portfolio
  - 9.3.1.3. Financial Overview
  - 9.3.1.4. Business Strategies and Development
- 9.3.2. Nipro Medical Corporation
  - 9.3.2.1. Company Overview
  - 9.3.2.2. Product Portfolio
  - 9.3.2.3. Financial Overview
  - 9.3.2.4. Business Strategies and Development
- 9.3.3. Medtronic
  - 9.3.3.1. Company Overview
  - 9.3.3.2. Product Portfolio
  - 9.3.3.3. Financial Overview
  - 9.3.3.4. Business Strategies and Development
- 9.3.4. Fresenius SE & Co KGaA
  - 9.3.4.1. Company Overview
  - 9.3.4.2. Product Portfolio
  - 9.3.4.3. Financial Overview
  - 9.3.4.4. Business Strategies and Development
- 9.3.5. Terumo Medical Corporation
  - 9.3.5.1. Company Overview
  - 9.3.5.2. Product Portfolio
  - 9.3.5.3. Financial Overview
  - 9.3.5.4. Business Strategies and Development
- 9.3.6. Getinge AB
  - 9.3.6.1. Company Overview
  - 9.3.6.2. Product Portfolio
  - 9.3.6.3. Financial Overview
  - 9.3.6.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations